Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.

I M Liu1, T C Chi, J T Cheng

  • 1Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan, ROC.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|April 11, 2001
PubMed
Summary

Vanadyl sulfate (VOSO4) treatment lowered blood glucose and reduced neuropeptide Y (NPY) gene expression in diabetic rats. This suggests VOSO4 may help manage diabetic hyperphagia by impacting NPY levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Efficacy and safety of percutaneous closure of ventricular septal rupture after acute myocardial infarction: a clinical study of 69 cases].

Zhonghua xin xue guan bing za zhi·2021
Same author

Analyses of the Tympanic Membrane Impulse Response Measured with High-Speed Holography.

Hearing research·2021
Same author

[Association between Lipoprotein(a) and the characteristics of left main coronary artery plaque in patients with stable angina pectoris].

Zhonghua yi xue za zhi·2019
Same author

[Effect of miR-19b on the proliferation and apoptosis of P19CL6 cells during the late-stage of cardiac differentiation].

Zhonghua yi xue za zhi·2018
Same author

[Association between the ApoB/A1 ratio and the vulnerability of LMCA plaque in the patients with stable angina pectoris].

Zhonghua yi xue za zhi·2017
Same author

Optimization of a lensless digital holographic otoscope system for transient measurements of the human tympanic membrane.

Experimental mechanics·2015

Area of Science:

  • Endocrinology
  • Neuroscience
  • Toxicology

Background:

  • Diabetes mellitus is characterized by hyperglycemia and altered feeding behaviors.
  • Neuropeptide Y (NPY) plays a crucial role in regulating appetite and energy balance.
  • Vanadium compounds are being investigated for their potential therapeutic effects in metabolic disorders.

Purpose of the Study:

  • To investigate the effect of vanadyl sulfate (VOSO4) on neuropeptide Y (NPY) gene expression in streptozotocin-induced diabetic rats.
  • To determine if VOSO4 administration influences plasma glucose levels, food and water intake, and body weight in diabetic and normal rats.

Main Methods:

  • Streptozotocin-induced diabetic rats and normal rats were orally administered vanadyl sulfate (VOSO4) at 1 mg/kg body weight, three times daily for one week.

Related Experiment Videos

  • Plasma glucose levels, food and water intake, and body weight were monitored.
  • Hypothalamic NPY mRNA levels and peptide concentrations were measured.

    • Main Results:

    • VOSO4 treatment significantly lowered plasma glucose levels and reduced food and water intake in STZ-diabetic rats.
    • The increase in hypothalamic NPY mRNA and peptide levels observed in STZ-diabetic rats was attenuated by VOSO4 treatment.
    • VOSO4 administration did not affect feeding behavior or hypothalamic NPY gene expression in normal rats.

    Conclusions:

    • Vanadyl sulfate (VOSO4) administration can ameliorate hyperglycemia and hyperphagia in diabetic rats.
    • The observed effects of VOSO4 in diabetic rats are associated with a decrease in hypothalamic NPY gene expression.
    • These findings suggest that VOSO4 may be a potential therapeutic agent for managing metabolic disturbances, particularly hyperphagia, in diabetes by modulating NPY pathways.